From BioNetwork Melbourne.
Register Now for Session 4
Market Drivers In Regenerative Medicine
LAST CHANCE TO REGISTER!
Join us on Tuesday 8 September - secure your place now
In this session Paul Brennan, Managing Director of PolyNovo, will share how PolyNovo enters various global markets, how they partner with key opinion leaders in the development of new products and what underlying drivers are used to assess product development priorities. With a Polymer that can be developed into many different medical devices, how does PolyNovo select from the embarrassment of choice?
Paul will be joined by additional panelist, Christelle Damiens, Managing Director of Exportia, for Q&A. Submit your question in advance here.
BioBusiness Insights is brought to you with support from our Premier Sponsor, the State Government of Victoria, and Supporting Sponsor, Clarivate Cortellis.
Session 4 Details
Date: Tuesday 8 September 2020
Time: 9:00 am - 10:00 am AEST
Format: This event will be delivered on a virtual platform – you will receive a link to join via a confirmation email following registration.
Registration:
Members $35; Non-members $45Unsure if your organisation is a member? Check our member directory
Already registered? Submit a question for Session 4 ahead of time
PNV - Banter and General Comments, page-2974
-
- There are more pages in this discussion • 9,216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.54 |
Change
-0.180(6.62%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.65 | $2.53 | $4.356M | 1.685M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 29641 | $2.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 22158 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |